US Patent Issued to Baylor College of Medicine on Jan. 20 for "Universal immune cells for cancer immunotherapy" (Texas Inventors)

ALEXANDRIA, Va., Jan. 20 -- United States Patent no. 12,528,871, issued on Jan. 20, was assigned to Baylor College of Medicine (Houston).

"Universal immune cells for cancer immunotherapy" was invented by Nabil M. Ahmed (Houston), Kevin Bielamowicz (Houston) and Kristen Fousek (Houston).

According to the abstract* released by the U.S. Patent & Trademark Office: "Embodiments of the disclosure encompass adoptive immunotherapy related to cells expressing multiple chimeric antigen receptors (CARs). In specific embodiments, T cells express a HER2-specific CAR, an IL13RAlpha2-specific CAR, and an EphA2-specific CAR. In particular embodiments, the cells are utilized for cancer treatment, including for glioblastoma."

The patent was filed on Jan. ...